Search clinical trials for: vildagliptin acarbose
Total 290 results
-
Radboud University Medical CenterCompletedType 2 Diabetes | Endothelial DysfunctionNetherlands
-
Peking UniversityUnknownObesity | Diabetes Mellitus, Type 2China
-
EMSCompletedType 2 Diabetes MellitusBrazil
-
Laboratorios Silanes S.A. de C.V.Recruiting
-
BayerCompletedDiabetes Mellitus, Type 2Germany
-
BayerCompletedDiabetes Mellitus, Type 2Germany
-
BayerCompleted
-
Novartis PharmaceuticalsCompletedType II Diabetes Mellitus | Congestive Heart FailureRussian Federation, Singapore, Italy, Czechia, Lithuania, Germany, Guatemala, India, Denmark, Estonia, Slovakia, Romania, Latvia, Greece, Poland
-
Novartis PharmaceuticalsCompletedType 2 Diabetes MellitusSpain, Poland, South Africa, Taiwan, Hong Kong, Norway, Italy, Bulgaria, Latvia, Lithuania, Germany, Turkey, Argentina, Israel, Korea, Republic of, Dominican Republic, Guatemala, Brazil, Colombia, Peru, Philippines, Russian Federation and more
-
Novartis PharmaceuticalsCompletedDiabetes Mellitus, Type 2Switzerland, Germany
-
Guiyang Medical UniversityNot yet recruitingHead and Neck Squamous CarcinomaChina
-
NovartisCompleted
-
The Cleveland ClinicCompleted
-
Novartis PharmaceuticalsCompletedDiabetes Mellitus, Type 2United States, Germany
-
The University of Texas Health Science Center at...Completed
-
GWT-TUD GmbHTechnische Universität Dresden; University of Regensburg; Diakonissen Krankenhaus...CompletedType 2 Diabetes Mellitus | Subclinical InflammationGermany
-
GWT-TUD GmbHCompleted
-
Technische Universität DresdenCompleted
-
Aichi Gakuin UniversityUnknownCoronary Artery Disease | Diabetes Mellitus | Impaired Glucose ToleranceJapan
-
Bio-innova Co., LtdNot yet recruiting
-
AgelessRxCompletedTolerance | Side Effect | Glucose ResponseUnited States
-
BayerCompletedDiabetes MellitusRussian Federation, India, Korea, Republic of, Indonesia, Malaysia, Philippines, Singapore, Thailand, China, Hong Kong, Pakistan, Vietnam, Algeria, Moldova, Republic of, Bosnia and Herzegovina, Cambodia
-
Karolinska InstitutetBayer; The Swedish Research CouncilCompleted
-
BayerCompletedDiabetes MellitusKorea, Republic of
-
BayerCompleted
-
BayerCompleted
-
University of Alabama at BirminghamNot yet recruitingKidney CancerUnited States
-
BayerCompleted
-
BayerCompleted
-
Lotus PharmaceuticalUnknownThe Objectives of the Study is to Evaluate the Efficacy and Safety of Acarmet (Metformin HCl 500 mg | Plus Acarbose 50 mg Tablets) Thrice Daily Versus Acarbose 50 mg Thrice Daily Over 16 Weeks in | Subjects With Type 2 Diabetes Mellitus.Taiwan
-
BayerCompleted
-
Ziv HospitalUnknownNon-Alcoholic Fatty Liver DiseaseIsrael
-
NovartisCompletedDiabetes Mellitus, Type 2United States, Germany
-
Novartis PharmaceuticalsCompletedDiabetes Mellitus, Type 2United States
-
Novartis PharmaceuticalsCompletedDiabetes Mellitus, Type 2United States
-
NovartisCompletedDiabetes Mellitus, Type 2Germany, United States
-
Novartis PharmaceuticalsCompletedDiabetes Mellitus, Type 2Switzerland
-
He XiaUnknown
-
Inje UniversitySanofiCompletedDiabetes Mellitus | Type 2 Diabetes MellitusKorea, Republic of
-
Royan InstituteCompletedPCOIran, Islamic Republic of
-
Novartis PharmaceuticalsCompletedDiabetes Mellitus, Type 2United States, Germany
-
NovartisCompletedDiabetes Mellitus, Type 2United States
-
NovartisCompletedDiabetes Mellitus, Type 2United States
-
Novartis PharmaceuticalsCompletedType 2 Diabetes MellitusEgypt
-
University of Campania "Luigi Vanvitelli"CompletedChronic Foot UlcersItaly
-
Novartis PharmaceuticalsCompletedDiabetes Mellitus, Type 2Switzerland
-
NovartisCompletedDiabetes Mellitus, Type 2Germany
-
NovartisCompletedDiabetes Mellitus, Type 2United States, Germany
-
NovartisCompletedDiabetes Mellitus, Type 2